OLE Study With Filgotinib in JIA

NCT07553182 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Idiopathic Arthritis (JIA)

Interventions

DRUG: Filgotinib

Sponsor

Alfasigma S.p.A.